HAN5:Volunteer Assignments and Opportunities - Revision history

Jennelleh at 19:07, 10 September 2024

2024-09-10T19:07:01Z

← Older revision		Revision as of 14:07, 10 September 2024
Line 6:		Line 6:

	To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.		To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.

	__TOC__		__TOC__
	{\| class="wikitable" style="margin:auto"		{\| class="wikitable" style="margin:auto"
Line 18:		Line 19:
	!'''Notes'''		!'''Notes'''
	\|-		\|-
	\|CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS)		\|
			==== CHAPTER 2 (NASAL, PARANASAL, AND SKULL BASE TUMOURS) ====
	\|		\|
	----		----
Line 302:		Line 304:
	\|		\|
	\|-		\|-
	\|CHAPTER 3 (NASOPHARYNGEAL TUMOURS)		\|
			==== CHAPTER 3 (NASOPHARYNGEAL TUMOURS) ====
	\|		\|
	----		----
Line 366:		Line 369:
	\|		\|
	\|-		\|-
	\|CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS)		\|
			==== CHAPTER 4 (HYPOPHARYNGEAL, LARYNGEAL, TRACHEA, AND PARAPHARYNGEAL TUMOURS) ====
	\|		\|
	----		----
Line 496:		Line 500:
	\|		\|
	\|-		\|-
	\|CHAPTER 5 (SALIVARY GLAND TUMOURS)		\|
			==== CHAPTER 5 (SALIVARY GLAND TUMOURS) ====
	\|		\|
	----		----
Line 945:		Line 950:
	\|		\|
	\|-		\|-
	\|CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS)		\|
			==== CHAPTER 6 (ORAL CAVITY AND MOBILE TONGUE TUMOURS) ====
	\|		\|
	----		----
Line 1,141:		Line 1,147:
	\|		\|
	\|-		\|-
	\|CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS))		\|
			==== CHAPTER 7 (OROPHARYNGEAL TUMOURS (BASE OF TONGUE, TONSILS, ADNOIDS)) ====
	\|		\|
	----		----
Line 1,194:		Line 1,201:
	\|		\|
	\|-		\|-
	\|CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS)		\|
			==== CHAPTER 8 (ODONTOGENIC AND MAXILLOFACIAL BONE TUMOURS) ====
	\|		\|
	----		----
Line 1,819:		Line 1,827:
	\|		\|
	\|-		\|-
	\|CHAPTER 9 (EAR TUMOURS)		\|
			==== CHAPTER 9 (EAR TUMOURS) ====
	\|		\|
	----		----
Line 1,993:		Line 2,002:
	\|		\|
	\|-		\|-
	\|CHAPTER 10 (SOFT TISSUE TUMOURS)		\|
			==== CHAPTER 10 (SOFT TISSUE TUMOURS) ====
	\|		\|
	----		----
Line 2,365:		Line 2,375:
	\|		\|
	\|-		\|-
	\|CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA)		\|
			==== CHAPTER 11 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) ====
	\|		\|
	----		----
Line 2,627:		Line 2,638:
	\|		\|
	\|-		\|-
	\|CHAPTER 12 (MELANOCYTIC TUMOURS)		\|
			==== CHAPTER 12 (MELANOCYTIC TUMOURS) ====
	\|		\|
	----		----
Line 2,658:		Line 2,670:
	\|		\|
	\|-		\|-
	\|CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES)		\|
			==== CHAPTER 13 (TUMOURS AND TUMOUR-IIKE LESIONS OF THE NECK AND LYMPH NODES) ====
	\|		\|
	----		----
Line 2,766:		Line 2,779:
	\|		\|
	\|-		\|-
	\|CHAPTER 14 (GERM CELL TUMOURS)		\|
			==== CHAPTER 14 (GERM CELL TUMOURS) ====
	\|		\|
	----		----
Line 2,797:		Line 2,811:
	\|		\|
	\|-		\|-
	\|CHAPTER 15 (METASTASIS)		\|
			==== CHAPTER 15 (METASTASIS) ====
	\|		\|
	----		----
Line 2,828:		Line 2,843:
	\|		\|
	\|-		\|-
	\|CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA)		\|
			==== CHAPTER 16 (NEUROENDOCRINE NEOPLASMS AND PARAGANGLIOMA) ====
	\|		\|
	----		----
Line 2,914:		Line 2,930:
	\|		\|
	\|-		\|-
	\|CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK)		\|
			==== CHAPTER 17 (GENETIC TUMOUR SYNDROMES INVOLVING THE HEAD AND NECK) ====
	\|		\|
	----		----

Jennelleh at 19:03, 10 September 2024

2024-09-10T19:03:26Z

← Older revision		Revision as of 14:03, 10 September 2024
Line 6:		Line 6:

	To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.		To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
			__TOC__
	{\| class="wikitable" style="margin:auto"		{\| class="wikitable" style="margin:auto"
	\|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>		\|+<big>WHO Classification of Head and Neck Tumours (5th Edition) Content</big>

Jennelleh at 21:40, 15 July 2024

2024-07-15T21:40:20Z

← Older revision		Revision as of 16:40, 15 July 2024
Line 3,001:		Line 3,001:
	\|[[HAN5:Multiple_endocrine_neoplasia_type_2\|Multiple endocrine neoplasia type 2]]		\|[[HAN5:Multiple_endocrine_neoplasia_type_2\|Multiple endocrine neoplasia type 2]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome\|Hyperparathyroidism-jaw tumour syndrome]]		\|[[HAN5:Hyperparathyroidism-jaw_tumour_syndrome\|Hyperparathyroidism-jaw tumour syndrome]]

Jennelleh at 22:05, 12 July 2024

2024-07-12T22:05:38Z

← Older revision		Revision as of 17:05, 12 July 2024
Line 2,946:		Line 2,946:
	\|[[HAN5:Neurofibromatosis_type_1\|Neurofibromatosis type 1]]		\|[[HAN5:Neurofibromatosis_type_1\|Neurofibromatosis type 1]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome\|Familial adenomatous polyposis and Gardner syndrome]]		\|[[HAN5:Familial_adenomatous_polyposis_and_Gardner_syndrome\|Familial adenomatous polyposis and Gardner syndrome]]

Jennelleh at 21:54, 12 July 2024

2024-07-12T21:54:15Z

← Older revision		Revision as of 16:54, 12 July 2024
Line 2,979:		Line 2,979:
	\|[[HAN5:Cowden_syndrome\|Cowden syndrome]]		\|[[HAN5:Cowden_syndrome\|Cowden syndrome]]
	\|Disease		\|Disease
	\|See DIG5 volunteer sheet for authorship status		\|[[DIG5:Volunteer Assignments and Opportunities\|See DIG5 volunteer sheet for authorship status]]
	\|N/A		\|N/A
	\|N/A		\|N/A

Jennelleh at 21:53, 12 July 2024

2024-07-12T21:53:44Z

← Older revision		Revision as of 16:53, 12 July 2024
Line 2,979:		Line 2,979:
	\|[[HAN5:Cowden_syndrome\|Cowden syndrome]]		\|[[HAN5:Cowden_syndrome\|Cowden syndrome]]
	\|Disease		\|Disease
	\|		\|See DIG5 volunteer sheet for authorship status
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Familial_paraganglioma_syndromes\|Familial paraganglioma syndromes]]		\|[[HAN5:Familial_paraganglioma_syndromes\|Familial paraganglioma syndromes]]

Jennelleh at 20:22, 12 July 2024

2024-07-12T20:22:56Z

← Older revision		Revision as of 15:22, 12 July 2024
Line 3,067:		Line 3,067:
	\|[[HAN5:Bloom_syndrome\|Bloom syndrome]]		\|[[HAN5:Bloom_syndrome\|Bloom syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Von_Hippel-Lindau_syndrome\|Von Hippel-Lindau syndrome]]		\|[[HAN5:Von_Hippel-Lindau_syndrome\|Von Hippel-Lindau syndrome]]

Jennelleh at 20:09, 12 July 2024

2024-07-12T20:09:42Z

← Older revision		Revision as of 15:09, 12 July 2024
Line 3,056:		Line 3,056:
	\|[[HAN5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]		\|[[HAN5:Ataxia-telangiectasia\|Ataxia-telangiectasia]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Bloom_syndrome\|Bloom syndrome]]		\|[[HAN5:Bloom_syndrome\|Bloom syndrome]]

Jennelleh at 20:00, 12 July 2024

2024-07-12T20:00:53Z

← Older revision		Revision as of 15:00, 12 July 2024
Line 3,034:		Line 3,034:
	\|[[HAN5:Fanconi_anaemia\|Fanconi anaemia]]		\|[[HAN5:Fanconi_anaemia\|Fanconi anaemia]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Dyskeratosis_congenita\|Dyskeratosis congenita]]		\|[[HAN5:Dyskeratosis_congenita\|Dyskeratosis congenita]]

Jennelleh at 19:36, 12 July 2024

2024-07-12T19:36:13Z

← Older revision		Revision as of 14:36, 12 July 2024
Line 3,023:		Line 3,023:
	\|[[HAN5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]		\|[[HAN5:Li-Fraumeni_syndrome\|Li-Fraumeni syndrome]]
	\|Disease		\|Disease
	\|		\|[[GTS5:Volunteer Assignments and Opportunities\|See GTS5 volunteer sheet for authorship status]]
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|		\|N/A
	\|-		\|-
	\|[[HAN5:Fanconi_anaemia\|Fanconi anaemia]]		\|[[HAN5:Fanconi_anaemia\|Fanconi anaemia]]